Bimatoprost ophthalmic solution 0.03% lowered intraocularpressure of normal-tension glaucoma with minimal adverse events [Corrigendum]

Tsumura T; Yoshikawa K; Suzumura H; Kimura T; Sasaki S; Kimura I; Takeda R. Clinical Opthalmology.

首页> 外文期刊>Clinical ophthalmology >Bimatoprost ophthalmic solution 0.03% lowered intraocularpressure of normal-tension glaucoma with minimal adverse events [Corrigendum]

【24h】

Bimatoprost ophthalmic solution 0.03% lowered intraocularpressure of normal-tension glaucoma with minimal adverse events [Corrigendum]

机译：比马前列素滴眼液降低了正常血压青光眼的眼内压0.03％，不良事件极少[勘误]

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical ophthalmology》 |2013年第6期|共2页
作者
Tsumura T; Yoshikawa K; Suzumura H; Kimura T; Sasaki S; Kimura I; Takeda R. Clinical Opthalmology.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum] [J] . Tsumura T, Yoshikawa K, Suzumura H, Clinical ophthalmology . 2013,第7期

机译：比马前列素滴眼液降低0.03％的正常血压青光眼眼内压，不良事件极少。 [更正]
2. Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events [J] . Toyoaki Tsumura, Keiji Yoshikawa, Hirotaka Suzumura, Clinical ophthalmology . 2012,第6期

机译：比马前列素滴眼液降低正常血压的青光眼的眼内压0.03％，不良事件最少
3. Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: A 12-week randomised controlled trial [J] . GoldbergI., GilPinaR., Lanzagorta-ArestiA., British journal of ophthalmology . 2014,第7期

机译：比马前列素0.03％/替莫洛尔0.5％不含防腐剂的眼药水与比马前列素0.03％/替莫洛尔0.5％眼药水（Ganfort）用于青光眼或高眼压症：一项为期12周的随机对照试验
4. Prior Prostaglandin Agonist Exposure and Conjunctival Hyperemia with Bimatoprost 0.03 Preservative-Free and Bimatoprost 0.03 Solutions in a Randomized, Multicenter Study [C] . Bejanian M., Liu C-C, Schiffman R. International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：先前前列腺素激动剂暴露和结膜充血与Bimatoprost 0.03％无保存和双咪替其前列素在随机的，多中心研究中的0.03％溶液
5. Hypersensitivity Adverse Event Reporting in Clinical Cancer Trials: Barriers and Potential Solutions to Studying Severe Events on a Population Level [D] . ?Eldredge, Christina 2020

机译：临床癌症试验中的超敏反不良事件报告：障碍和潜在的解决方案，用于研究人口水平的严重事件
6. Bimatoprost ophthalmic solution 0.03 lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. Corrigendum [O] . 2013

机译：比马前列素滴眼液降低0.03％的正常血压青光眼眼内压不良事件最少。更正
7. Bimatoprost ophthalmic solution 0.03 lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. Corrigendum [O] . Toyoaki Tsumura, Hirotaka Suzumura, Keiji Yoshikawa 2013

机译：Bimatoprost眼科溶液随着常规不良事件的常规张力青光眼的眼压降低0.03％。逆变

Bimatoprost ophthalmic solution 0.03% lowered intraocularpressure of normal-tension glaucoma with minimal adverse events [Corrigendum]

著录项

相似文献

相关主题

期刊订阅